Teleflex Inc (TFX) Stock Price, Quote & News

Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 610-225-6800

Website: www.teleflex.com

Address:

550 East Swedesford Road, Suite 400, Wayne, United States

StockNews_Live Mar. 12 at 12:02 PM

$TFX 🎯 STOCK NEWS ALERT 💵 Price: $111.66 (-0.08%) 🔥 Sentiment Score: 95/100 🚀 VERY POSITIVE NEWS 📄 o9 Announces Teleflex Global Go-Live for Integrated Demand and Supply Planning. The company has successfully implemented a global demand and supply planning system, enabling real-time visibility and… 📎 https://stocknews.live/news/TFX/o9-announces-teleflex-tm-84472.html

0 · Reply

NewsAndFilings Mar. 11 at 7:16 PM

Medical Alert $BSX, $TFX, $ARAY, $CSDX, $NDRA Highlight Growing Hydrogel Tissue Spacer Market in Radiation Oncology https://thestreetreports.com/medical-alert-bsx-tfx-aray-csdx-ndra-highlight-growing-hydrogel-tissue-spacer-market-in-radiation-oncology/

0 · Reply

erevnon Feb. 27 at 5:48 PM

Wells Fargo maintains Teleflex $TFX at Equal-Weight and raises the price target from $116 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

ZacksResearch Feb. 27 at 1:40 PM

$TFX misses big on Q4 earnings & revenue estimates. 📉 Despite 28.7% YoY GAAP revenue growth to $569M, GAAP EPS fell short of the Zacks Consensus Estimate by 48.3%, and GAAP revenue by 38.6%. Fundamental insights here 👉 https://www.zacks.com/stock/news/2876511/tfx-q4-earnings-revenues-miss-margins-down-stock-up-in-after-market?cid=sm-stocktwits-2-2876511-body-35446&ADID=SYND_STOCKTWITS_TWEET_2_2876511_BODY_35446

0 · Reply

ZacksResearch Feb. 27 at 12:40 PM

$TFX Q4 miss — yet the stock jumps? 📈 Earnings and revenues fell short, margins shrank, but after-hours gains came on 2026 growth guidance and a portfolio reshuffle. Find out what’s driving the rally 👉 https://www.zacks.com/stock/news/2876511/tfx-q4-earnings-revenues-miss-margins-down-stock-up-in-after-market?cid=sm-stocktwits-2-2876511-teaser-35445&ADID=SYND_STOCKTWITS_TWEET_2_2876511_TEASER_35445

0 · Reply

StocktwitsEarnings Feb. 26 at 12:09 PM

$TFX Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$16.15 down -447.46% YoY • Reported revenue of $568.98M down -28.47% YoY • Teleflex expects 2026 GAAP revenue growth of 14.40% to 15.40% and adjusted diluted EPS from continuing operations of $6.25 to $6.55. The company anticipates pro forma adjusted constant currency revenue growth between 4.50% and 5.50%.

0 · Reply

SuperGreenToday Feb. 12 at 3:01 AM

$TFX Share Price: $106.95 Contract Selected: Jul 17, 2026 $105 Calls Buy Zone: $8.67 – $10.71 Target Zone: $14.69 – $17.95 Potential Upside: 60% ROI Time to Expiration: 155 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

DiamondCapital Feb. 11 at 5:16 PM

$CSDX one to look into asap tick tock. Their CS Protect-Hydrogel is currently under FDA review High value/low competition niche(hydrogel spacers) •SpaceOAR™ Hydrogel System acquired by $BSX Boston Scientific for $500M •Barrigel® acquired by Telefex $TFX for $600M And literally no other direct competitors in market This is a pretty big OTC play. High value/low competition niche(hydrogel spacers), which seen major buyouts in the past. In the range of $500M-$600M. Not your typical OTC play. The potential is just massive on this one

0 · Reply

OfficialStocktwitsUser Feb. 3 at 1:13 AM

$TFX RSI: 38.17, MACD: -3.9248 Vol: 7.92, MA20: 108.04, MA50: 115.31 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

DiamondCapital Feb. 2 at 3:06 PM

$CSDX Put this on your watchlist asap Their CS Protect-Hydrogel currently under FDA review Competitors: SpaceOAR™ Hydrogel System which was acquired by $BSX Boston Scientific for $500M Barrigel® acquired by Telefex $TFX for $600M And literally no other direct competitors in market Another similar one but not a (hydrogel spacer) is BioProtect Balloon Implant™ System currently in the process of being acquired for $200M as of Jan,26, 2026 This is a pretty big OTC play. High value/low competition niche(hydrogel spacers), which seen major buyouts in the past. In the range of $500M-$600M Going to share more DD on this play..

1 · Reply

o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning

Mar 3, 2026, 2:00 AM EST - 13 days ago

Teleflex: More Clarity And More Questions

Feb 26, 2026, 5:08 PM EST - 17 days ago

Teleflex Incorporated (TFX) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 6:45 AM EST - 17 days ago

Teleflex Announces Quarterly Dividend

Feb 26, 2026, 6:30 AM EST - 17 days ago

Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook

Feb 17, 2026, 6:30 AM EST - 26 days ago

Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information

Jan 8, 2026, 6:30 AM EST - 2 months ago

Teleflex Announces Leadership Transition

Dec 10, 2025, 4:18 PM EST - 3 months ago

Teleflex: Selling, But How Much?

Dec 9, 2025, 9:20 AM EST - 3 months ago

Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

Dec 9, 2025, 9:12 AM EST - 3 months ago

Teleflex to sell three of its businesses for $2.03 billion

Dec 9, 2025, 9:04 AM EST - 3 months ago

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Nov 18, 2025, 7:18 AM EST - 4 months ago

Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 14, 2025, 1:21 PM EST - 4 months ago

Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript

Nov 14, 2025, 6:30 AM EST - 4 months ago

Teleflex to Present at the Jefferies Global Healthcare Conference in London

Nov 7, 2025, 2:41 PM EST - 4 months ago

These Analysts Cut Their Forecasts On Teleflex Following Q3 Results

Nov 6, 2025, 11:16 AM EST - 4 months ago

Teleflex Incorporated (TFX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 6:30 AM EST - 4 months ago

Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

Oct 16, 2025, 4:30 PM EDT - 5 months ago

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

Sep 11, 2025, 6:30 AM EDT - 6 months ago

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

Sep 10, 2025, 12:21 PM EDT - 6 months ago

Teleflex Incorporated (TFX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 26, 2025, 6:30 AM EDT - 7 months ago

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 19, 2025, 6:30 AM EDT - 7 months ago

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

Jul 31, 2025, 7:14 PM EDT - 8 months ago

Teleflex Incorporated (TFX) Q2 2025 Earnings Conference Call Transcript

Jul 31, 2025, 6:30 AM EDT - 8 months ago

Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook

Jul 25, 2025, 11:15 AM EDT - 8 months ago

Chest Drainage Catheters Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Leading Players - BD, Teleflex, Cook, ICU Medical, and Redax

Jul 17, 2025, 6:30 AM EDT - 8 months ago

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information

Jul 1, 2025, 6:30 AM EDT - 9 months ago

Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business

Jun 12, 2025, 6:30 AM EDT - 9 months ago

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

Jun 11, 2025, 6:30 AM EDT - 9 months ago

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month

May 19, 2025, 6:30 AM EDT - 10 months ago

Teleflex Publishes 2024 Global Impact Report

May 15, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Shareholders to Learn More About the Investigation

May 15, 2025, 6:30 AM EDT - 10 months ago

Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting

May 14, 2025, 10:00 AM EDT - 10 months ago

Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 13, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Shareholders to Inquire about Securities Investigation

May 13, 2025, 6:30 AM EDT - 10 months ago

New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy

May 12, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Shareholders to Connect

May 11, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Investors to Connect

May 9, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Stockholders to Inquire about Securities Investigation

May 8, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Investors to Learn More About the Investigation

May 7, 2025, 10:00 AM EDT - 11 months ago

Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 7, 2025, 9:31 AM EDT - 11 months ago

TFX Investors Have Opportunity to Join Teleflex Incorporated Fraud Investigation with the Schall Law Firm

May 5, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Stockholders to Learn More About the Investigation

May 4, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Investors to Inquire about Securities Investigation

May 2, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teleflex Incorporated (TFX) And Encourages Investors to Reach Out

StockNews_Live Mar. 12 at 12:02 PM

0 · Reply

NewsAndFilings Mar. 11 at 7:16 PM

0 · Reply

erevnon Feb. 27 at 5:48 PM

Wells Fargo maintains Teleflex $TFX at Equal-Weight and raises the price target from $116 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

ZacksResearch Feb. 27 at 1:40 PM

0 · Reply

ZacksResearch Feb. 27 at 12:40 PM

0 · Reply

StocktwitsEarnings Feb. 26 at 12:09 PM

0 · Reply

SuperGreenToday Feb. 12 at 3:01 AM

0 · Reply

DiamondCapital Feb. 11 at 5:16 PM

0 · Reply

OfficialStocktwitsUser Feb. 3 at 1:13 AM

0 · Reply

DiamondCapital Feb. 2 at 3:06 PM

1 · Reply

mielk92 Jan. 22 at 7:57 PM

$TFX Did they already start the buybacks?

0 · Reply

Valuation_Finance Jan. 21 at 2:35 PM

$TFX This stock is pretty widely followed. We had 3 value name investors buy in Q3 2025 and some insider buys last Summer at $115. That's why people are here, not because of anything exciting TFX does or makes. People figure there is a Superinvestor put here and we aren't too far away from the bottom.

1 · Reply

Valuation_Finance Jan. 20 at 5:06 PM

$TFX No, it's because Liam Kelly quit. If you bring back Kelly, it will go back up to $110. Why are you in the company in the first place?

1 · Reply

InvestingInPoop Jan. 20 at 3:36 PM

$TFX sorry guys, it’s down because I entered a position last week. I should do the honorable thing and sell so it can go back up

0 · Reply

BillionerOfKing Jan. 14 at 6:26 PM

$TFX Current Stock Price: $103.14 Contracts to trade: $100 TFX Jan 16 2026 Call Entry: $2.55 Exit: $4.33 ROI: 70% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

medguy Jan. 8 at 6:37 PM

Out with small gains $TFX

0 · Reply

medguy Jan. 8 at 3:12 PM

Looking for a bounce $RGC $TFX

0 · Reply

bluffmeariver Jan. 8 at 2:19 PM

$TFX why crashing

0 · Reply

JarvisFlow Dec. 18 at 4:05 PM

Truist Securities updates rating for Teleflex ( $TFX ) to Hold, target set at 120 → 135.

0 · Reply

ZacksResearch Dec. 17 at 1:27 PM

$TFX down 29.9% over the past year — is it a buying opportunity or a value trap? 🤔 📉 High debt & FX headwinds remain concerns 📈 UroLift & Barrigel drive growth in prostate care with expanding global presence 💡 5.4% average earnings surprise over the trailing four quarters See what makes the investment case strong for Teleflex 👉 https://www.zacks.com/stock/news/2805395/should-you-retain-teleflex-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2805395-body-25111&ADID=SYND_STOCKTWITS_TWEET_2_2805395_BODY_25111

0 · Reply

ZacksResearch Dec. 17 at 12:27 PM

$TFX: Long-term story intact — but is the pressure worth it right now? ⚖️ UroLift expansion and Barrigel traction are supporting long-term growth, but high debt levels and FX headwinds are keeping the stock under pressure and clouding the near-term picture. Weigh the upside vs. the risks here 👉 https://www.zacks.com/stock/news/2805395/should-you-retain-teleflex-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2805395-teaser-25110&ADID=SYND_STOCKTWITS_TWEET_2_2805395_TEASER_25110

0 · Reply

JarvisFlow Dec. 10 at 8:11 PM

Wells Fargo updates rating for Teleflex ( $TFX ) to Equal-Weight, target set at 114 → 139.

0 · Reply

Market Cap	4.74B
Revenue (ttm)	1.99B
Net Income (ttm)	-905.64M
EPS (ttm)	N/A
PE Ratio	8.77
Forward PE	15.82
Profit Margin	-45.45%
Debt to Equity Ratio	0.70

Volume	694,700
Avg Vol	1,011,822
Day's Range	N/A - N/A
Shares Out	44.20M
Stochastic %K	1%
Beta	0.87
Analysts	Hold
Price Target	$133.00